Guibin Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guibin Xu has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
Zhiduan Cai
11 shared publicationsYuyu Xu
Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
8 shared publicationsWenjun Luo
7 shared publicationsRui Zhu
Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
5 shared publicationsHaoquan Zhuang
Department of Urology, Key Laboratory of Biological Targeting Diagnosis Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University Guangzhou China
3 shared publicationsHaoran Wang
Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
3 shared publications
Latest Publications
- 29 January 2026
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 87, 102617
NanoPhyto Formulations: A Promising Approach for Targeted Therapy of Gastrointestinal Infections, Clinical Advancements, and Future Perspectives
- 29 January 2026
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 87, 102617
NanoPhyto Formulations: A Promising Approach for Targeted Therapy of Gastrointestinal Infections, Clinical Advancements, and Future Perspectives
- Open Access
- 21 November 2025
- Published by Springer Nature in Urolithiasis
- Vol. 53 (1) , 225
Inconsistency in stone composition among bilateral urolithiasis patients: a multicenter retrospective study
The treatment or prevention strategies vary for different stone compositions. The current guidelines lack specific recommendations for composition analysis in bilateral urolithiasis due to limited data on the analysis of bilateral urinary stone composition. We aimed to calculate the prevalence of discordant stone compositions among bilateral urolithiasis patients, and identify factors associated with the discordance. We retrospectively enrolled 845 bilateral urolithiasis patients across seven centers in China, whose stones on both sides were analyzed separately for stone composition. We calculated the percent prevalence of discordant stone compositions among bilateral urolithiasis patients. Univariate analyses and multivariate logistic regression analyses were used to identify factors associated with this discordance. A total of 24.9% of enrolled patients had discordant stone compositions of bilateral uroliths, which ranged from 17.5 to 32.4% in the seven institutions. Among the 210 patients with discordant stone compositions, the two most common composition combinations were calcium oxalate/carbapatite (51.0%) and calcium oxalate/uric acid (35.7%). Four clinical variables, including sex, age, predominant component of calcium oxalate on one side, and predominant component of uric acid on one side, were associated with a stone composition inconsistency among bilateral urolithiasis in the multivariate logistic analyses. Notably, the pretreatment urinalysis results and preoperative serum biochemical parameters were not related to the stone composition inconsistency. Approximately one-quarter of the patients were identified as discordant stone formers among the bilateral urolithiasis patients in our study, highlighting the importance of separately analyzing the stone composition on both sides in patients with bilateral urolithiasis.
- 21 November 2025
- Published by Springer Nature in Urolithiasis
- Vol. 53 (1) , 225
Open AccessInconsistency in stone composition among bilateral urolithiasis patients: a multicenter retrospective study
The treatment or prevention strategies vary for different stone compositions. The current guidelines lack specific recommendations for composition analysis in bilateral urolithiasis due to limited data on the analysis of bilateral urinary stone composition. We aimed to calculate the prevalence of discordant stone compositions among bilateral urolithiasis patients, and identify factors associated with the discordance. We retrospectively enrolled 845 bilateral urolithiasis patients across seven centers in China, whose stones on both sides were analyzed separately for stone composition. We calculated the percent prevalence of discordant stone compositions among bilateral urolithiasis patients. Univariate analyses and multivariate logistic regression analyses were used to identify factors associated with this discordance. A total of 24.9% of enrolled patients had discordant stone compositions of bilateral uroliths, which ranged from 17.5 to 32.4% in the seven institutions. Among the 210 patients with discordant stone compositions, the two most common composition combinations were calcium oxalate/carbapatite (51.0%) and calcium oxalate/uric acid (35.7%). Four clinical variables, including sex, age, predominant component of calcium oxalate on one side, and predominant component of uric acid on one side, were associated with a stone composition inconsistency among bilateral urolithiasis in the multivariate logistic analyses. Notably, the pretreatment urinalysis results and preoperative serum biochemical parameters were not related to the stone composition inconsistency. Approximately one-quarter of the patients were identified as discordant stone formers among the bilateral urolithiasis patients in our study, highlighting the importance of separately analyzing the stone composition on both sides in patients with bilateral urolithiasis.
- Open Access
- 12 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Novel Flexible Ureteroscopic System for intrarenal pelvic and intracaliceal pressure measurement in porcine models
This study evaluates the consistency between intrarenal pelvic pressures (IPP) and intracaliceal pressures (ICP) and explores the impacts of irrigation flow rate (IFR) and ureteral access sheath (UAS) position on ICP using a novel Flexible Ureteroscope Pressure Measurement System. Six pigs with 12 kidneys were included in this study under general anesthesia. The IPP and ICP were measured using the Flexible Ureteroscopic Pressure Measurement System under varying UAS positions and IFRs. The 12/14Fr UAS was sequentially placed in the upper, middle, and lower segments of the porcine ureters. The irrigation pump was set to cumulative flow rates of 20, 30, 40, and 50 mL/min. Hemodynamic parameters were monitored using the Edwards Lifesciences monitoring system. The experiment was successfully completed in 10 kidneys. One kidney failed due to issues with UAS placement, and another was penetrated by the UAS. No significant difference was observed between the middle calyx ICP and IPP. ICP in the upper and lower calyces was higher than IPP, with the discrepancy being minor at 20 or 30 mL/min IFR but significant at higher IFRs of 40 and 50 mL/min. The ICP increased with higher IFRs and when the UAS was set in the low ureteral segment. Under the same IFR and UAS position, ICP varied among the three calyces (lower calyx > upper calyx > middle calyx). The Edwards Lifesciences monitoring system accurately measured hemodynamic parameters, which remained stable even at an IFR of 50 mL/min. The Flexible Ureteroscopic Pressure Measurement System can be used to measure the IPP and ICP. These pressures were not consistent across different IFRs and UAS positions. The highest ICP was observed in the lower calyx.
- 12 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessNovel Flexible Ureteroscopic System for intrarenal pelvic and intracaliceal pressure measurement in porcine models
This study evaluates the consistency between intrarenal pelvic pressures (IPP) and intracaliceal pressures (ICP) and explores the impacts of irrigation flow rate (IFR) and ureteral access sheath (UAS) position on ICP using a novel Flexible Ureteroscope Pressure Measurement System. Six pigs with 12 kidneys were included in this study under general anesthesia. The IPP and ICP were measured using the Flexible Ureteroscopic Pressure Measurement System under varying UAS positions and IFRs. The 12/14Fr UAS was sequentially placed in the upper, middle, and lower segments of the porcine ureters. The irrigation pump was set to cumulative flow rates of 20, 30, 40, and 50 mL/min. Hemodynamic parameters were monitored using the Edwards Lifesciences monitoring system. The experiment was successfully completed in 10 kidneys. One kidney failed due to issues with UAS placement, and another was penetrated by the UAS. No significant difference was observed between the middle calyx ICP and IPP. ICP in the upper and lower calyces was higher than IPP, with the discrepancy being minor at 20 or 30 mL/min IFR but significant at higher IFRs of 40 and 50 mL/min. The ICP increased with higher IFRs and when the UAS was set in the low ureteral segment. Under the same IFR and UAS position, ICP varied among the three calyces (lower calyx > upper calyx > middle calyx). The Edwards Lifesciences monitoring system accurately measured hemodynamic parameters, which remained stable even at an IFR of 50 mL/min. The Flexible Ureteroscopic Pressure Measurement System can be used to measure the IPP and ICP. These pressures were not consistent across different IFRs and UAS positions. The highest ICP was observed in the lower calyx.
- 9 December 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 287, 138545
Biocompatible, biodegradable, and anticancer alginate-quercetin ureteral stent via co-axial extrusion technique
- 9 December 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 287, 138545
Biocompatible, biodegradable, and anticancer alginate-quercetin ureteral stent via co-axial extrusion technique
- Open Access
- 5 October 2024
- Published by Springer Nature in BMC Urology
- Vol. 24 (1) , 1-7
Safety and efficacy of thermo-expandable metallic stent in ureteral stricture following gynecological malignancy surgery and radiotherapy: a single center experience with 33 cases
The effectiveness of metallic stents in treating ureteral strictures following surgery and radiotherapy for gynecological tumors is currently uncertain. We aimed to investigate the efficacy and safety of thermo-expandable metallic stent (Memokath) in the treatment of ureteral stricture after radiotherapy for gynecological tumors. In this descriptive cross-sectional study, 27 patients with ureteral stricture were treated with Memokath stent after gynecological tumor radiotherapy with or without chemotherapy that was admitted to our hospital from August 2021 to August 2023. Clinical data on efficacy, safety, and complications during stent insertion and indwelling were analyzed. The successful insertion of thirty-three stents in twenty-seven patients studied. The stenosis length was 10.14 ± 6.76 cm, and the hospitalization was 4.43 ± 1.83 days. One patient has died from the primary disease carrying a patency stent. The Kaplan-Meier graph showed that the cumilative patency rate of patients with thermo-expandable metallic stent were 92.4% (SD = 5.2%) in eight months, 77.4% (9.1%) in 12 months and 67.7% (SD = 12%) in 29 months, while the cumilative survival rate was 87.5% (SD = 11.5%) in 29 months. The stent patency was 81.48% and later complications of stent indwelling were 5/27, including refractory urinary tract infection (UTI) in three cases, stent migration, and stent intolerance respectively. The creatinine levels, hydronephrosis degree, and glomerular filtration rate improved after the operation, and the first two indicators were statistically significant. Memokath stent is a safe and effective treatment for ureteral stricture after surgery and radiotherapy with or without chemotherapy for gynecological tumors.
- 5 October 2024
- Published by Springer Nature in BMC Urology
- Vol. 24 (1) , 1-7
Open AccessSafety and efficacy of thermo-expandable metallic stent in ureteral stricture following gynecological malignancy surgery and radiotherapy: a single center experience with 33 cases
The effectiveness of metallic stents in treating ureteral strictures following surgery and radiotherapy for gynecological tumors is currently uncertain. We aimed to investigate the efficacy and safety of thermo-expandable metallic stent (Memokath) in the treatment of ureteral stricture after radiotherapy for gynecological tumors. In this descriptive cross-sectional study, 27 patients with ureteral stricture were treated with Memokath stent after gynecological tumor radiotherapy with or without chemotherapy that was admitted to our hospital from August 2021 to August 2023. Clinical data on efficacy, safety, and complications during stent insertion and indwelling were analyzed. The successful insertion of thirty-three stents in twenty-seven patients studied. The stenosis length was 10.14 ± 6.76 cm, and the hospitalization was 4.43 ± 1.83 days. One patient has died from the primary disease carrying a patency stent. The Kaplan-Meier graph showed that the cumilative patency rate of patients with thermo-expandable metallic stent were 92.4% (SD = 5.2%) in eight months, 77.4% (9.1%) in 12 months and 67.7% (SD = 12%) in 29 months, while the cumilative survival rate was 87.5% (SD = 11.5%) in 29 months. The stent patency was 81.48% and later complications of stent indwelling were 5/27, including refractory urinary tract infection (UTI) in three cases, stent migration, and stent intolerance respectively. The creatinine levels, hydronephrosis degree, and glomerular filtration rate improved after the operation, and the first two indicators were statistically significant. Memokath stent is a safe and effective treatment for ureteral stricture after surgery and radiotherapy with or without chemotherapy for gynecological tumors.
- 28 August 2024
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 165, 214009
Natural biopolymers in the fabrication and coating of ureteral stent: An overview
- 28 August 2024
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 165, 214009
Natural biopolymers in the fabrication and coating of ureteral stent: An overview
- Open Access
- 26 August 2024
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 52 (8)
Use of a Memokath™ 045 temperature-controlled memory alloy stent for treating upper renal calyx calyceal neck atresia: a case report
Renal calyceal neck atresia is a rare disorder. There is no clear guidance for standard treatment of this condition. The Memokath™ 045 temperature-controlled memory alloy stent is commonly used in the treatment of urethral strictures, but it has not been used for treating calyceal neck atresia. We present a case of a 44-year-old female patient with left lumbar pain who underwent two stages of treatment to resolve calyceal neck atresia located at the upper calyx of her left kidney. The first procedure was transurethral ureteroscopy combined with percutaneous recanalization of the left upper calyx calyceal neck atresia. One 6 F internal stent and one 8 F internal stent were placed, and she was discharged with a left nephrostomy tube. After her urinary tract infection was fully resolved, the patient returned for the second procedure of percutaneous upper renal calyx calyceal neck metal stent implantation. The temporary stents and nephrostomy tube were successfully removed. Our findings suggest that the Memokath™ 045 temperature-controlled memory alloy stent is an effective choice for treating calyceal neck atresia.
- 26 August 2024
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 52 (8)
Open AccessUse of a Memokath™ 045 temperature-controlled memory alloy stent for treating upper renal calyx calyceal neck atresia: a case report
Renal calyceal neck atresia is a rare disorder. There is no clear guidance for standard treatment of this condition. The Memokath™ 045 temperature-controlled memory alloy stent is commonly used in the treatment of urethral strictures, but it has not been used for treating calyceal neck atresia. We present a case of a 44-year-old female patient with left lumbar pain who underwent two stages of treatment to resolve calyceal neck atresia located at the upper calyx of her left kidney. The first procedure was transurethral ureteroscopy combined with percutaneous recanalization of the left upper calyx calyceal neck atresia. One 6 F internal stent and one 8 F internal stent were placed, and she was discharged with a left nephrostomy tube. After her urinary tract infection was fully resolved, the patient returned for the second procedure of percutaneous upper renal calyx calyceal neck metal stent implantation. The temporary stents and nephrostomy tube were successfully removed. Our findings suggest that the Memokath™ 045 temperature-controlled memory alloy stent is an effective choice for treating calyceal neck atresia.
- 8 August 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 100
Drug-eluting ureteral stents: An overview
- 8 August 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 100
Drug-eluting ureteral stents: An overview
- Open Access
- 30 April 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 42 (1) , 1-7
Risk factors for migration of retrievable covered expandable metallic stent in patients with persistent benign ureter strictures
Purpose: The purpose of this study is to evaluate the incidence, risk factors, and salvage management of retrievable covered expandable metallic stent (RCEMS) migration in patients with persistent benign ureter strictures. Materials and methods: A retrospective study was performed on 117 consecutive patients who underwent implantation of RCEMS. Univariate and multivariate analyses were used to identify prognostic factors for stent migration, including stricture location and length, hydronephrosis–cortex ratio, ureteral dilation, and the diameter of the narrowest portion of the stricture. Results: Stent migration occurred in 22 (19.5%) of 113 patients who met inclusion criteria. Of the 22 patients, 16 (72.7%) had ordinary ureteral stricture, 3 (13.6%) had stricture in transplanted kidneys, and 3 patients (13.6%) had ureter stricture in orthotopic neobladders. The mean creatinine for the entire cohorts showed significant improvement (p = 0.038). Multivariate analysis identified the following prognostic factors for migration: distal ureteral stricture (p = 0.006), patients who underwent balloon dilation (p = 0.003), hydronephrosis–cortex ratio ≧10 (p = 0.017), larger diameter of wasting of RCEMS (p < 0.001), and patients with a shorter stricture length (p = 0.006). Salvage management was required in 4 of the 22 patients. The strictures in the remaining 18 patients improved with observation. Conclusions: Stent migration is more likely to occur in patients with the five prognostic factors mentioned above. Our study developed a nomogram to predict stent migration in patients with ureteral strictures treated using RCEMS.
- 30 April 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 42 (1) , 1-7
Open AccessRisk factors for migration of retrievable covered expandable metallic stent in patients with persistent benign ureter strictures
Purpose: The purpose of this study is to evaluate the incidence, risk factors, and salvage management of retrievable covered expandable metallic stent (RCEMS) migration in patients with persistent benign ureter strictures. Materials and methods: A retrospective study was performed on 117 consecutive patients who underwent implantation of RCEMS. Univariate and multivariate analyses were used to identify prognostic factors for stent migration, including stricture location and length, hydronephrosis–cortex ratio, ureteral dilation, and the diameter of the narrowest portion of the stricture. Results: Stent migration occurred in 22 (19.5%) of 113 patients who met inclusion criteria. Of the 22 patients, 16 (72.7%) had ordinary ureteral stricture, 3 (13.6%) had stricture in transplanted kidneys, and 3 patients (13.6%) had ureter stricture in orthotopic neobladders. The mean creatinine for the entire cohorts showed significant improvement (p = 0.038). Multivariate analysis identified the following prognostic factors for migration: distal ureteral stricture (p = 0.006), patients who underwent balloon dilation (p = 0.003), hydronephrosis–cortex ratio ≧10 (p = 0.017), larger diameter of wasting of RCEMS (p < 0.001), and patients with a shorter stricture length (p = 0.006). Salvage management was required in 4 of the 22 patients. The strictures in the remaining 18 patients improved with observation. Conclusions: Stent migration is more likely to occur in patients with the five prognostic factors mentioned above. Our study developed a nomogram to predict stent migration in patients with ureteral strictures treated using RCEMS.